NanoViricides
NNVC
#10132
Rank
NZ$38.43 M
Marketcap
NZ$2.14
Share price
0.82%
Change (1 day)
-13.96%
Change (1 year)

NanoViricides (NNVC) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : NZ$2.26 Million

According to NanoViricides's latest financial reports the company's total liabilities are NZ$2.26 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

NanoViricides - Total liabilities on balance sheet (from 2006 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-06-30NZ$2.22 M-32.83%
2023-06-30NZ$3.31 M401.32%
2022-06-30NZ$0.66 M31.82%
2021-06-30NZ$0.5 M-84.99%
2020-06-30NZ$3.34 M-21.1%
2019-06-30NZ$4.23 M225.29%
2018-06-30NZ$1.3 M-85.73%
2017-06-30NZ$9.12 M-52.06%
2016-06-30NZ$19.03 M4.19%
2015-06-30NZ$18.27 M-21.86%
2014-06-30NZ$23.38 M115.45%
2013-06-30NZ$10.85 M389.43%
2012-06-30NZ$2.21 M212.85%
2011-06-30NZ$0.7 M-80.18%
2010-06-30NZ$3.57 M344.56%
2009-06-30NZ$0.8 M-40.27%
2008-06-30NZ$1.34 M21.81%
2007-06-30NZ$1.1 M-55.1%
2006-06-30NZ$2.46 M2451.37%
2005-06-30NZ$0.09 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
BioCryst Pharmaceuticals
BCRX
NZ$1.44 B 63,757.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
NZ$2.32 B 102,199.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$64.37 B 2,837,744.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$135.92 B 5,992,077.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$134.79 B 5,942,327.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$106.40 B 4,690,559.16%๐Ÿ‡ฌ๐Ÿ‡ง UK